关键词: 癫痫; 惊厥性癫痫持续状态; 医疗质量; 质量控制指标

Abstract: Epilepsy is one of the five major neuropsychiatric diseases that the World Health Organization (WHO) focuses on prevention and treatment. From June 2017 to the present, the Epilepsy Working Group of National Center for Healthcare Quality Management in Neurological Diseases has launched the national epilepsy medical quality indicator system after three batches of pilots, based on full reference to domestic and overseas evidence-based evidence and previous indicator experience. It has built a medical quality control system for epilepsy and convulsive status epilepticus covering 130 sentinel hospitals in 31 provincial administrative regions across China. Regarding on the diagnosis and treatment indicator data feedback from sentinel hospitals, the system was revised based on the published quality control indicators. Twenty validated indicators in epilepsy and convulsive status epilepticus were included. In 2020, the General Office of the National Health Commission issued the indicator system. Disease quality control indicators rely on the national quality control network system to implement medical quality control and management, aiming at improving medical quality and promoting the homogenization of diagnosis and treatment. Currently, this indicator system has been incorporated into the accreditation standards for tertiary hospitals. In addition to strengthening the training, analysis and feedback of information on the indicators, the standardized diagnosis and treatment of epilepsy and convulsive status epilepticus in medical institutions at all levels are constantly promoted.

Key words: Epilepsy; Convulsive status epilepticus; Medical quality; Quality control indicator